Journal
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
Volume 32, Issue 3, Pages 733-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2018.05.001
Keywords
Clostridium difficile infection; Solid organ transplant; Prevention; Infection control; Antimicrobial stewardship; Treatment; Fecal microbiota transplant
Categories
Ask authors/readers for more resources
Clostridium difficile infection is a significant cause of morbidity and mortality in solid organ transplant recipients. Risk factors in this population include frequent hospitalizations, receipt of immunosuppressive agents, and intestinal dysbiosis triggered by several factors, including exposure to broad-spectrum antimicrobials. The incidence and potential for significant adverse outcomes among solid organ transplant recipients with C difficile infection highlight the evolving need for strategic C difficile infection risk factor modification and novel approaches to disease management in this patient population. This article focuses on current concepts related to the prevention and treatment of C difficile infection in solid organ transplant recipients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available